問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberC3601002
Completed

2018-05-01 - 2023-05-17

Phase III

Not yet recruiting6

Terminated1

ICD-10A49.9

Bacterial infection, unspecified

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator Chung-Yu Chen Division of General Internal Medicine

Co-Principal Investigator

  • 周俊志 Division of General Internal Medicine
  • 周建宏 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Ming -Cheng Chan Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Po-Liang Lu Division of Infectious Disease

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Audit

None

Principal Investigator Susan Shin-Jung Lee Division of General Internal Medicine

Co-Principal Investigator

  • 陳瑞光 Division of General Internal Medicine
  • 周稚偵 Division of General Internal Medicine
  • 張博閔 Division of General Internal Medicine
  • 施正蓮 Division of General Internal Medicine
  • 梁宗榮 Division of General Internal Medicine
  • 吳冠陞 Division of General Internal Medicine
  • 陳以書 Division of General Internal Medicine
  • 蔡忠育 Division of General Internal Medicine
  • 陳垚生 Division of General Internal Medicine
  • 曾鈺婷 Division of General Internal Medicine
  • 王國強 Division of General Internal Medicine

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Wang-Huei Sheng Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Audit

None

Principal Investigator Chung-Yu Chen Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    16 participants

  • Global

    426 participants